Cargando…
Real World Evidence in Medical Cannabis Research
BACKGROUND: Whilst access to cannabis-based medicinal products (CBMPs) has increased globally subject to relaxation of scheduling laws globally, one of the main barriers to appropriate patient access remains a paucity of high-quality evidence surrounding their clinical effects. DISCUSSION: Whilst ra...
Autores principales: | Banerjee, Rishi, Erridge, Simon, Salazar, Oliver, Mangal, Nagina, Couch, Daniel, Pacchetti, Barbara, Sodergren, Mikael Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688379/ https://www.ncbi.nlm.nih.gov/pubmed/34748204 http://dx.doi.org/10.1007/s43441-021-00346-0 |
Ejemplares similares
-
Cannabinoids in the landscape of cancer
por: Mangal, Nagina, et al.
Publicado: (2021) -
Medical cannabis, CBD wellness products and public awareness of evolving regulations in the United Kingdom
por: Erridge, Simon, et al.
Publicado: (2022) -
Perceived Stigma of Patients Undergoing Treatment with Cannabis-Based Medicinal Products
por: Troup, Lucy J., et al.
Publicado: (2022) -
Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis‐Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry
por: Kawka, Michal, et al.
Publicado: (2021) -
UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomes
por: Nimalan, Devaki, et al.
Publicado: (2022)